Contineum Therapeutics Inc (CTNM)

Jun 03, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Boosts Holdings in Contineum Therapeutics, Inc. (NASDAQ:CTNM) - Defense World

Jun 03, 2025

Jun 02, 2025

Deutsche Bank AG Purchases New Shares in Contineum Therapeutics, Inc. (NASDAQ:CTNM) - Defense World

Jun 02, 2025

May 28, 2025

Northern Trust Corp Increases Stock Holdings in Contineum Therapeutics, Inc. (NASDAQ:CTNM) - Defense World

May 28, 2025

May 27, 2025

Contineum Therapeutics ATM - Leerink Partners

May 27, 2025

May 20, 2025

Contineum Therapeutics’ SWOT analysis: pipeline progress buoys stock outlook By Investing.com - Investing.com South Africa

May 20, 2025

May 20, 2025

Contineum Therapeutics’ SWOT analysis: pipeline progress buoys stock outlook - Investing.com

May 20, 2025

May 20, 2025

Contineum Therapeutics (NASDAQ:CTNM) Price Target Lowered to $20.00 at Morgan Stanley - Defense World

May 20, 2025

May 17, 2025

Contineum Therapeutics (NASDAQ:CTNM) Earns Outperform Rating from Royal Bank of Canada - Defense World

May 17, 2025

May 15, 2025

Contineum Therapeutics to Present at the 2025 RBC Capital Markets Global Healthcare Conference - BioSpace

May 15, 2025

May 14, 2025

Contineum Therapeutics Reports First-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones - BioSpace

May 14, 2025

May 14, 2025

Contineum Therapeutics May 2025 slides: Multiple shots on goal with 2H25 catalysts ahead - Investing.com India

May 14, 2025

May 12, 2025

Barclays PLC Buys 7,978 Shares of Contineum Therapeutics, Inc. (NASDAQ:CTNM) - Defense World

May 12, 2025

May 10, 2025

Wells Fargo & Company MN Raises Position in Contineum Therapeutics, Inc. (NASDAQ:CTNM) - Defense World

May 10, 2025

May 08, 2025

Contineum Therapeutics (CTNM) Expected to Announce Earnings on Thursday - Defense World

May 08, 2025

May 06, 2025

(CTNM) Investment Analysis - news.stocktradersdaily.com

May 06, 2025

May 03, 2025

Contineum Therapeutics (NASDAQ:CTNM) versus Longeveron (NASDAQ:LGVN) Financial Survey - Defense World

May 03, 2025

May 02, 2025

JPMorgan Chase & Co. Has $416,000 Holdings in Contineum Therapeutics, Inc. (NASDAQ:CTNM) - Defense World

May 02, 2025

Apr 30, 2025

Contineum Therapeutics Appoints Timothy Watkins, M.D., M.Sc., As Chief Medical Officer - citybiz

Apr 30, 2025

Apr 29, 2025

Geode Capital Management LLC Purchases 59,732 Shares of Contineum Therapeutics, Inc. (NASDAQ:CTNM) - Defense World

Apr 29, 2025

Apr 29, 2025

Contineum Therapeutics Appoints Timothy Watkins, M.D., M.Sc., as Chief Medical Officer and Head of Development - BioSpace

Apr 29, 2025

Apr 28, 2025

Contineum Therapeutics Appoints Timothy Watkins As Chief Medical Officer And Head Of Development - marketscreener.com

Apr 28, 2025

Apr 28, 2025

Form 8-KCurrent report - ADVFN

Apr 28, 2025

Apr 24, 2025

Critical Contrast: Contineum Therapeutics (CTNM) and Its Rivals - Defense World

Apr 24, 2025

Apr 23, 2025

We're Not Very Worried About Contineum Therapeutics' (NASDAQ:CTNM) Cash Burn Rate - Yahoo Finance

Apr 23, 2025

Apr 22, 2025

Contineum Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - ADVFN

Apr 22, 2025

Apr 21, 2025

(CTNM) On The My Stocks Page - news.stocktradersdaily.com

Apr 21, 2025

Apr 15, 2025

Contineum Therapeutics (CTNM) vs. Its Competitors Head-To-Head Survey - Defense World

Apr 15, 2025

Apr 10, 2025

Contineum Therapeutics, Inc. (NASDAQ:CTNM) Receives $24.80 Consensus PT from Analysts - Defense World

Apr 10, 2025

Apr 08, 2025

Contineum Therapeutics Rings the Nasdaq Stock Market Closing Bell - Nasdaq

Apr 08, 2025

Apr 08, 2025

Contineum Therapeutics Rings the Closing Bell - Nasdaq

Apr 08, 2025

Apr 05, 2025

How the (CTNM) price action is used to our Advantage - news.stocktradersdaily.com

Apr 05, 2025

Mar 31, 2025

Charles Schwab Investment Management Inc. Has $811,000 Stock Position in Contineum Therapeutics, Inc. (NASDAQ:CTNM) - Defense World

Mar 31, 2025

Mar 31, 2025

Charles Schwab Investment Management Inc. Buys 12,035 Shares of Contineum Therapeutics, Inc. (NASDAQ:CTNM) - The AM Reporter

Mar 31, 2025

Mar 30, 2025

Bank of New York Mellon Corp Has $275,000 Stake in Contineum Therapeutics, Inc. (NASDAQ:CTNM) - Defense World

Mar 30, 2025

Mar 25, 2025

Long Term Trading Analysis for (CTNM) - news.stocktradersdaily.com

Mar 25, 2025

Mar 17, 2025

Contineum Therapeutics Announces Appointment of Diego Miralles, M.D. to Its Board of Directors - BioSpace

Mar 17, 2025

Mar 16, 2025

Analysts Set Contineum Therapeutics, Inc. (NASDAQ:CTNM) Target Price at $24.80 - Defense World

Mar 16, 2025

Mar 15, 2025

(CTNM) Investment Report - news.stocktradersdaily.com

Mar 15, 2025

Mar 15, 2025

Jones Trading Begins Coverage on Contineum Therapeutics (NASDAQ:CTNM) - Defense World

Mar 15, 2025

Mar 13, 2025

Jones Trading Initiates Coverage of Contineum Therapeutics (CTNM) with Buy Recommendation - Nasdaq

Mar 13, 2025

Mar 13, 2025

JonesTrading Initiates Contineum Therapeutics at Buy With $23 Price Target -March 13, 2025 at 08:48 am EDT - Marketscreener.com

Mar 13, 2025

Mar 13, 2025

Institutional investors in Contineum Therapeutics, Inc. (NASDAQ:CTNM) have had a wonderful week after share price increased 24% - Yahoo Finance

Mar 13, 2025